From October 1, 2022 to November 16, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 380,360 shares, representing 1.86% for KRW 4,984.4 million under the buyback announced on May 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,500 KRW | +2.86% | -1.44% | -0.49% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.49% | 365M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.